Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2018 (2018), Article ID 9468912, 2 pages
https://doi.org/10.1155/2018/9468912
Editorial

Genomics Approach of the Natural Product Pharmacology for High Impact Diseases

1Lifescience School, Beijing University of Chinese Medicine, Beijing, China
2Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Department of Medicine, Emory University, Atlanta, GA, USA
4Digestive Diseases and Nutrition Center, Women and Children’s Hospital of Buffalo, Department of Pediatrics, the State University of New York at Buffalo, Buffalo, NY, USA
5Department of Nutrition, University of Tennessee, Knoxville, TN, USA

Correspondence should be addressed to Lixin Zhu; ude.olaffub@uhznixil

Received 21 March 2018; Accepted 21 March 2018; Published 8 April 2018

Copyright © 2018 Yong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020, 2013, World Health Organization, Geneva, 2015.
  2. A. L. Harvey, R. Edrada-Ebel, and R. J. Quinn, “The re-emergence of natural products for drug discovery in the genomics era,” Nature Reviews Drug Discovery, vol. 14, no. 2, pp. 111–129, 2015. View at Publisher · View at Google Scholar
  3. X. Liang, X. Chen, Q. Liang et al., “Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats,” Journal of Proteome Research, vol. 10, no. 2, pp. 790–799, 2011. View at Publisher · View at Google Scholar
  4. X. Fan, X. Li, S. Lv, Y. Wang, Y. Zhao, and G. Luo, “Comparative proteomics research on rat MSCs differentiation induced by Shuanglong Formula,” Journal of Ethnopharmacology, vol. 131, no. 3, pp. 575–580, 2010. View at Publisher · View at Google Scholar
  5. Y. Wang, W. Lin, C. Li et al., “Multipronged therapeutic effects of Chinese herbal medicine Qishenyiqi in the treatment of acute myocardial infarction,” Frontiers in Pharmacology, vol. 8, 2017. View at Publisher · View at Google Scholar
  6. L.-X. Feng, C.-J. Jing, K.-L. Tang et al., “Clarifying the signal network of salvianolic acid B using proteomic assay and bioinformatic analysis,” Proteomics, vol. 11, no. 8, pp. 1473–1485, 2011. View at Publisher · View at Google Scholar
  7. Q. Feng, W. Liu, S. S. Baker et al., “Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease,” Oncotarget, vol. 8, no. 17, pp. 27820–27838, 2017. View at Publisher · View at Google Scholar
  8. J. Wang, X. F. Tan, V. S. Nguyen et al., “A quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasis,” Molecular & Cellular Proteomics, vol. 13, no. 3, pp. 876–886, 2014. View at Publisher · View at Google Scholar
  9. Z. Liu, F. Guo, Y. Wang et al., “BATMAN-TCM: a bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine,” Scientific Reports, vol. 6, no. 1, article 21146, 2016. View at Publisher · View at Google Scholar
  10. X. Wang, A. Zhang, P. Wang et al., “Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies,” Molecular and Cellular Proteomics, vol. 12, no. 5, pp. 1226–1238, 2013. View at Publisher · View at Google Scholar